Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-9 of 9 for Movement disorders

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Establish a Parkinson’s Disease (PD) Cohort using the Parkinson’s Progression Markers Initiative (PPMI)

    Scottsdale/Phoenix, AZ

  2. A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

    Scottsdale/Phoenix, AZ

  3. A Study to Establish a Registry of Deep Brain Stimulation with the VERCISE™ System

    Jacksonville, FL

  4. A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

    Jacksonville, FL

  5. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease

    Scottsdale/Phoenix, AZ

  6. A Study to Evaluate Quantitative Phenotypes of Movement Disorders

    Jacksonville, FL

  7. Multiple System Atrophy

    Rochester, MN

  8. Electrophysiological Biomarkers for Parkinson's Disease

    Scottsdale/Phoenix, AZ

  9. A Study on Mayo Clinic Patients with Friedreich Ataxia

    Rochester, MN

.

Mayo Clinic Footer